What is the recommended zolpidem dose for adults, elderly patients, and individuals with hepatic impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Zolpidem Dosing

The recommended starting dose of zolpidem is 5 mg for all women and 5-10 mg for men, taken once nightly immediately before bedtime with at least 7-8 hours remaining before awakening; elderly patients and those with hepatic impairment should receive 5 mg regardless of sex. 1

Standard Adult Dosing

  • Women: Start with 5 mg due to slower drug clearance (approximately 45% higher blood levels compared to men at the same dose) 1
  • Men: Start with either 5 mg or 10 mg 1
  • Maximum dose: 10 mg once daily for immediate-release formulations 1

The sex-based dosing difference is critical because women metabolize zolpidem more slowly, leading to higher morning blood levels and increased risk of next-day impairment, particularly affecting driving ability 2, 1. This FDA labeling change in 2013 followed discovery of the link between blood drug levels and driving impairments 2.

Elderly Patients (≥65 years)

Dose: 5 mg once nightly regardless of sex 1

Elderly patients are especially sensitive to zolpidem's effects due to:

  • Reduced drug clearance compared to younger adults 3
  • Higher risk of falls (93% of fall reports occurred in patients ≥70 years, with 82% taking doses >10 mg) 1
  • Increased confusion risk (75% of confusion reports in patients ≥70 years, with 78% on doses >10 mg) 1

The pharmacokinetic differences are substantial: elderly men show decreased oral clearance (3.8 vs 11.0 ml/min/kg in young men) and increased peak concentrations (93 vs 40 ng/ml) 3.

Hepatic Impairment

Mild to moderate hepatic impairment: 5 mg once nightly 1

Severe hepatic impairment: Avoid zolpidem entirely as it may contribute to encephalopathy 1

Patients with hepatic impairment clear zolpidem more slowly than healthy subjects, necessitating dose reduction 1. The absolute contraindication in severe hepatic disease reflects the risk of worsening hepatic encephalopathy.

Extended-Release Formulations

For zolpidem extended-release (if prescribed):

  • Women: 6.25 mg (reduced from previous 12.5 mg recommendation) 4
  • Men: 12.5 mg 4
  • Elderly: 6.25 mg regardless of sex 5

Critical Prescribing Considerations

Common pitfall: A study found 28.9% of women were still receiving 10 mg zolpidem doses despite FDA warnings—this represents inappropriate prescribing 6. The 10 mg dose in women increases risk of next-day impairment of driving and activities requiring full alertness 1.

Timing: Take as a single dose immediately before bedtime; do not readminister during the same night 1. Food delays absorption and reduces effectiveness 1.

CNS depressants: When combining with other CNS depressants, dosage adjustment downward may be necessary due to additive effects 1.

The American Academy of Sleep Medicine provides a weak recommendation for zolpidem use in sleep onset and maintenance insomnia, based on trials using 10 mg doses, though they acknowledge FDA's subsequent lowering of recommended starting doses to 5 mg 4. The evidence quality was rated as "very low" due to heterogeneity and publication bias, but benefits were judged to outweigh minimal harms 4.

References

Guideline

patterns of zolpidem use in male and female veterans following revised fda dosing guidelines.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018

Guideline

clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an american academy of sleep medicine clinical practice guideline.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2017

Research

Zolpidem modified-release in insomnia.

Neuropsychiatric disease and treatment, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.